Pharmaceuticals, Biotechnology and Life Sciences
— Targeting Unmet Needs for Treating Solid Tumors– REDWOOD CITY, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) — Bolt Biotherapeutics, Inc.,…
WARREN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), is a…
PASADENA, CALIF., Feb. 10, 2025 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW),…
HARRISBURG, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) — RxTechExam and the Pennsylvania Pharmacists Association (PPA) have announced a strategic partnership…
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral…
SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025,…
Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million Received CE Mark for…
BOSTON, Feb. 10, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to…
GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Feb. 10, 2025 (GLOBE NEWSWIRE) — Revolo Biotherapeutics Limited (“Revolo”) today announced that it…
Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31,…